MB, S., AM, P., H, T., & MK, G. (2022). Neoantigens - the next frontier in precision immunotherapy for B-cell lymphoproliferative disorders. Blood reviews, 56, 100969. https://doi.org/10.1016/j.blre.2022.100969
Chicago Style (17th ed.) CitationMB, Sabdia, Patch AM, Tsang H, and Gandhi MK. "Neoantigens - the Next Frontier in Precision Immunotherapy for B-cell Lymphoproliferative Disorders." Blood Reviews 56 (2022): 100969. https://doi.org/10.1016/j.blre.2022.100969.
MLA (9th ed.) CitationMB, Sabdia, et al. "Neoantigens - the Next Frontier in Precision Immunotherapy for B-cell Lymphoproliferative Disorders." Blood Reviews, vol. 56, 2022, p. 100969, https://doi.org/10.1016/j.blre.2022.100969.
Warning: These citations may not always be 100% accurate.